ResearcherHenry Ford HealthActive in the last 2 years

Qing‐Sheng Mi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1411-6827; OpenAlex author ID A5076317415. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

Corrigendum to "scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic cancer liver metastasis" [Cancer Let… Last author DOI 10.1016/j.canlet.2024.217071 ↗
scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic cancer liver metastasis. Last author DOI 10.1016/j.canlet.2023.216149 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bin Chen · 2 shared papers, 2023–2024 · strength 0.35
- Paper Corrigendum to "scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancrea… DOI 10.1016/j.canlet.2024.217071 ↗
- Paper scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic cancer liver… DOI 10.1016/j.canlet.2023.216149 ↗
Ian M. Loveless · 2 shared papers, 2023–2024 · strength 0.35
- Paper Corrigendum to "scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancrea… DOI 10.1016/j.canlet.2024.217071 ↗
- Paper scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic cancer liver… DOI 10.1016/j.canlet.2023.216149 ↗
Qijun Yi · 2 shared papers, 2023–2024 · strength 0.35
- Paper Corrigendum to "scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancrea… DOI 10.1016/j.canlet.2024.217071 ↗
- Paper scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic cancer liver… DOI 10.1016/j.canlet.2023.216149 ↗
Howard C. Crawford · 2 shared papers, 2023–2024 · strength 0.35
- Paper Corrigendum to "scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancrea… DOI 10.1016/j.canlet.2024.217071 ↗
- Paper scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic cancer liver… DOI 10.1016/j.canlet.2023.216149 ↗
Jie Wang · 1 shared paper, 2024 · strength 0.19
- Paper Corrigendum to "scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancrea… DOI 10.1016/j.canlet.2024.217071 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.